In the British Columbia FH cohort, Lp(a) was found higher than in the general reference population, but there was no difference in Lp(a) plasma levels between carriers of LDLR or APOB pathogenic variants compared with noncarriers (78). The gene discussed is LDLR; the disease is familial hyperaldosteronism.